Factors Affecting Buprenorphine Utilization and Spending in Medicaid, 2002-2018

Buprenorphine is an essential medication for the treatment of opioid use disorder (OUD), but studies show it has been underused over the last 2 decades. We sought to evaluate utilization of and spending on buprenorphine formulations in Medicaid and to evaluate the impact of key market and regulatory factors affecting availability of different formulations and generic versions.

Source: Value in Health - October 21, 2020 Category: International Medicine & Public Health Authors: Rachel E. Barenie, Michael S. Sinha, Aaron S. Kesselheim Source Type: research